Evidence map›Paper›PMID 35582032›Full record

ArticleCancer drug resistance (Alhambra, Calif.)2021

ABCA1 is associated with the development of acquired chemotherapy resistance and predicts poor ovarian cancer outcome.

Wanqi Wang, Noor A Lokman, Tannith M Noye, Anne M Macpherson, Martin K Oehler, Carmela Ricciardelli

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancer drug resistance (Alhambra, Calif.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.4field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Chemoresistance in Ovarian Cancer and Association with Circadian Rhythm.Reproductive sciences (Thousand Oaks, Calif.) · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Roles of ABCA1 in cancer.Oncology letters · 2022
    Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Wanqi WangAdelaide Medical School, Robinson Research Institute, University of Adelaide, Adelaide, SA 5000, Australia.
Noor A LokmanAdelaide Medical School, Robinson Research Institute, University of Adelaide, Adelaide, SA 5000, Australia.
Tannith M NoyeAdelaide Medical School, Robinson Research Institute, University of Adelaide, Adelaide, SA 5000, Australia.
Anne M MacphersonAdelaide Medical School, Robinson Research Institute, University of Adelaide, Adelaide, SA 5000, Australia.
Martin K OehlerAdelaide Medical School, Robinson Research Institute, University of Adelaide, Adelaide, SA 5000, Australia.
Carmela RicciardelliAdelaide Medical School, Robinson Research Institute, University of Adelaide, Adelaide, SA 5000, Australia.
University of Adelaide · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ABCA1ABCB1ABCB3ABCC2ABCG2ABC transporterapabetalonechemotherapy resistanceHGSOCTAP2

Identifiers

PMID35582032
PMCPMC9019266
OpenAlexW3132033260

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.